Medtronic stock rallies 2.02% and outperforms competitors

10 articles · Updated · MarketWatch · Apr 30

Shares closed at $80.97 on Thursday, with trading volume of 15.7 million, well above the 50-day average of 8.3 million.
The gain ended a four-day losing streak during a broader market rise, as the S&P 500 climbed 1.02% and the Dow Jones Industrial Average added 1.62%.
Medtronic still finished 23.85% below its 52-week high of $106.33, while Johnson & Johnson and Danaher rose and Abbott Laboratories fell.

Is Medtronic's strategic split a true turnaround or a value trap for investors?

After the spinoff, does Medtronic have the right focus to win the MedTech arms race?

Can Medtronic's new surgical robots and AI tools overcome its recent product recalls?